Concord Drugs Limited (CONCORD.BO)
INR 36.45
(-2.72%)
INR 36.45
(-2.72%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 449.24 Million | 520.8 Million | 589.56 Million | 513.57 Million | 513.38 Million | 481.53 Million |
| Cost of Revenue | 332.54 Million | 410.29 Million | 421.36 Million | 430.71 Million | 427.02 Million | 399.78 Million |
| Gross Profit | 116.7 Million | 110.51 Million | 168.2 Million | 82.85 Million | 86.36 Million | 81.74 Million |
| Operating Expenses | 91.83 Million | 79.95 Million | 76.6 Million | 62.87 Million | 67.56 Million | 61.7 Million |
| Selling, General and Administrative Expenses | 60.76 Million | 3.57 Million | 3.47 Million | 4.19 Million | 2.77 Million | 26.42 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 93 Thousand | 28 Thousand | 25 Thousand | 4360.00 | 20 Thousand | - |
| Cost and Expenses | 424.37 Million | 490.25 Million | 497.96 Million | 493.59 Million | 494.58 Million | 461.49 Million |
| Operating Income | 24.87 Million | 29.46 Million | 39.14 Million | 19.41 Million | 19.68 Million | 20.22 Million |
| Interest Expense | 18.67 Million | 17.28 Million | 16.76 Million | 13.31 Million | 14.46 Million | 15.7 Million |
| Income Tax Expense | 1.56 Million | 2.63 Million | 6.53 Million | 10.1 Million | 1.28 Million | 328 Thousand |
| Earnings before Tax | 6.28 Million | 12.48 Million | 22.48 Million | 42.91 Million | 4.56 Million | 4.39 Million |
| Net Income | 4.72 Million | 9.85 Million | 15.94 Million | 32.81 Million | 3.28 Million | 4.07 Million |
| Earnings Per Share Basic | 0.47 | 1.06 | 1.82 | 3.75 | 0.38 | 0.52 |
| Earnings Per Share Diluted | 0.47 | 1.06 | 1.82 | 3.75 | 0.38 | 0.52 |
| Weighted Average Shares Outstanding | 10.05 Million | 9.31 Million | 8.74 Million | 8.74 Million | 8.74 Million | 7.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.05 Million | 9.31 Million | 8.74 Million | 8.74 Million | 8.74 Million | 7.86 Million |
| Gross Margin | 0.26 | 0.21 | 0.29 | 0.16 | 0.17 | 0.17 |
| EBIT Margin | 0.09 | 0.09 | 0.18 | 0.06 | 0.07 | 0.08 |
| Profit Margin | 0.01 | 0.02 | 0.03 | 0.06 | 0.01 | 0.01 |
| EBITDA | 40.52 Million | 45.8 Million | 56.78 Million | 32.82 Million | 34.32 Million | 37.34 Million |
| Earnings Before Tax Margin | 0.06 | 0.06 | 0.07 | 0.04 | 0.04 | 0.04 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 116.92 Million | 449.24 Million | 156.42 Million | 127.83 Million | 75.16 Million | 89.81 Million |
| Cost of Revenue | 90.21 Million | 332.54 Million | 132.52 Million | 101.21 Million | 40.91 Million | 57.88 Million |
| Gross Profit | 26.71 Million | 116.7 Million | 23.89 Million | 26.62 Million | 34.25 Million | 31.92 Million |
| Operating Expenses | 21.77 Million | 91.83 Million | 24.34 Million | 24.22 Million | 22 Million | 21.17 Million |
| Selling, General and Administrative Expenses | 14.58 Million | - | 16.9 Million | 15.39 Million | 14.63 Million | 13.83 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 21.77 Million | 93 Thousand | 62 Thousand | - | 81 Thousand | - |
| Cost and Expenses | 111.99 Million | 424.37 Million | 156.87 Million | 125.43 Million | 62.92 Million | 79.05 Million |
| Operating Income | 4.93 Million | 24.96 Million | -435 Thousand | 2.39 Million | 12.16 Million | 10.75 Million |
| Interest Expense | 4.52 Million | 18.67 Million | 5.03 Million | 4.96 Million | 4.26 Million | 4.4 Million |
| Income Tax Expense | 135 Thousand | 1.56 Million | -2.08 Million | -157 Thousand | 2.36 Million | 1.44 Million |
| Earnings before Tax | 408 Thousand | 6.29 Million | -5.47 Million | -2.56 Million | 7.98 Million | 6.35 Million |
| Net Income | 273 Thousand | 4.72 Million | -3.38 Million | -2.41 Million | 5.61 Million | 4.9 Million |
| Earnings Per Share Basic | 0.03 | - | -0.34 | -0.24 | 0.60 | 0.53 |
| Earnings Per Share Diluted | 0.03 | - | -0.34 | -0.24 | 0.60 | 0.53 |
| Weighted Average Shares Outstanding | 9.1 Million | 10.05 Million | 10.05 Million | 10.05 Million | 9.36 Million | 9.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 9.1 Million | 10.05 Million | 10.05 Million | 10.05 Million | 9.36 Million | 9.25 Million |
| Gross Margin | 0.23 | 0.26 | 0.15 | 0.21 | 0.46 | 0.36 |
| EBIT Margin | 0.07 | - | 0.02 | 0.05 | 0.21 | 0.16 |
| Profit Margin | 0.00 | 0.01 | -0.02 | -0.02 | 0.07 | 0.05 |
| EBITDA | 8.32 Million | - | 3.5 Million | 6.29 Million | 16.12 Million | 14.59 Million |
| Earnings Before Tax Margin | 0.04 | 0.06 | -0.00 | 0.02 | 0.16 | 0.12 |
VBSN
JUBILE
TKUN
300805
RNDOF
DRMTY